<DOC>
	<DOC>NCT01427725</DOC>
	<brief_summary>This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients receiving the treatment with LipaCreon for a long term in order to evaluate the effective and safe use of LipaCreon.</brief_summary>
	<brief_title>Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Pancreatic Diseases</mesh_term>
	<criteria>Inclusion Criteria Patients who receive LipaCreon for the replacement of pancreatic digestive enzymes in pancreatic exocrine insufficiency Exclusion Criteria Patients with a history of hypersensitivity to the ingredient of LipaCreon. Patients with a history of hypersensitivity to porcine protein.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pancreatectomy</keyword>
	<keyword>Gastrointestinal Agents</keyword>
	<keyword>Pancreatic Diseases</keyword>
	<keyword>Pancrelipase</keyword>
	<keyword>Exocrine Pancreatic Insufficiency</keyword>
</DOC>